Concepedia
Statistics
Publications
8
Citations
397
H-Index
Active since
2019
Affiliations
Paul Scherrer Institute(Current)
ETH Zurich
University of Gothenburg
South African Nuclear Energy Corporation (South Africa)
Institut Laue-Langevin
Viviane J. Tschan is an author at Paul Scherrer Institute.
Publications per year
2019–2023
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Cristina Müller, Christoph A. Umbricht, Nadezda Gracheva et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 215 citations · Full text
[225Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [225Ac]Ac-PSMA-617
Sarah D. Busslinger, Viviane J. Tschan, O.K. Richard et al. · Cancers · 2022 · 34 citations · Full text
Albumin-Binding and Conventional PSMA Ligands in Combination with<sup>161</sup>Tb: Biodistribution, Dosimetry, and Preclinical Therapy
Viviane J. Tschan, Sarah D. Busslinger, Peter Bernhardt et al. · Journal of Nuclear Medicine · 2023 · 34 citations · Full text
Preclinical investigations using [177Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer
Viviane J. Tschan, Francesca Borgna, Sarah D. Busslinger et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 33 citations · Full text
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer
Michele Garioni, Viviane J. Tschan, Lauriane Blukacz et al. · npj Precision Oncology · 2023 · 24 citations · Full text
Rows per page
1–5 of 8